Posted on Tuesday, February 04, 2014 at 11:27 am CST
Global Markets Direct's, 'Hyperalgesia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperalgesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperalgesia. Hyperalgesia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:22 am CST
Global Market Direct's pharmaceuticals report, "Pfenex Inc. - Product Pipeline Review - 2013" provides data on the Pfenex Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:17 am CST
Global Market Direct's pharmaceuticals report, "Medisyn Technologies, Inc. - Product Pipeline Review - 2013" provides data on the Medisyn Technologies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:14 am CST
Global Market Direct's pharmaceuticals report, "Nerviano Medical Sciences S.r.l. - Product Pipeline Review - 2013" provides data on the Nerviano Medical Sciences S.r.l.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:08 am CST
Global Market Direct's pharmaceuticals report, "Morvus Technology Ltd - Product Pipeline Review - 2013" provides data on the Morvus Technology Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:03 am CST
Global Market Direct's pharmaceuticals report, "A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2013" provides data on the A. Menarini Industrie Farmaceutiche Riunite Srl's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 11:02 am CST
Global Market Direct's pharmaceuticals report, "Avaxia Biologics, Inc. - Product Pipeline Review - 2013" provides data on the Avaxia Biologics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:43 am CST
Global Market Direct's pharmaceuticals report, "MabVax Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the MabVax Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:31 am CST
Global Market Direct's pharmaceuticals report, "EirGen Pharma Ltd. - Product Pipeline Review - 2013" provides data on the EirGen Pharma Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:23 am CST
Global Markets Direct's, 'Tachycardia (Tachyarrhythmias) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Tachycardia (Tachyarrhythmias), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tachycardia (Tachyarrhythmias). Tachycardia (Tachyarrhythmias) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:22 am CST
Global Markets Direct's, 'Ulcers - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ulcers. Ulcers - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:19 am CST
Global Market Direct's pharmaceuticals report, "Charlesson LLC. - Product Pipeline Review - 2013" provides data on the Charlesson LLC.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:14 am CST
Global Market Direct's pharmaceuticals report, "Rhizen Pharmaceuticals SA - Product Pipeline Review - 2013" provides data on the Rhizen Pharmaceuticals SA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:13 am CST
Global Market Direct's pharmaceuticals report, "Novo Nordisk A/S - Product Pipeline Review - 2013" provides data on the Novo Nordisk A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 10:10 am CST
Global Market Direct's pharmaceuticals report, "Digna Biotech, S.L. - Product Pipeline Review - 2013" provides data on the Digna Biotech, S.L.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:56 am CST
Global Market Direct's pharmaceuticals report, "Biodel Inc. - Product Pipeline Review - 2013" provides data on the Biodel Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:54 am CST
Global Market Direct's pharmaceuticals report, "Bial - Portela & Ca, S.A. - Product Pipeline Review - 2013" provides data on the Bial - Portela & Ca, S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:53 am CST
Global Market Direct's pharmaceuticals report, "Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2013" provides data on the Intra-Cellular Therapies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:50 am CST
Global Market Direct's pharmaceuticals report, "PsychoGenics, Inc. - Product Pipeline Review - 2013" provides data on the PsychoGenics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:49 am CST
Global Markets Direct's, 'Arteriosclerosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Arteriosclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arteriosclerosis. Arteriosclerosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:45 am CST
Global Market Direct's pharmaceuticals report, "SWITCH Biotech LLC - Product Pipeline Review - 2013" provides data on the SWITCH Biotech LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:40 am CST
Global Markets Direct's, 'Aplastic Anemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Aplastic Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Aplastic Anemia. Aplastic Anemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:29 am CST
Global Market Direct's pharmaceuticals report, "Pro-Cure Therapeutics Limited - Product Pipeline Review - 2013" provides data on the Pro-Cure Therapeutics Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:24 am CST
Global Market Direct's pharmaceuticals report, "Mnemosyne Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Mnemosyne Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, February 04, 2014 at 9:11 am CST
Global Markets Direct's, 'Bullous Pemphigoid - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bullous Pemphigoid, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bullous Pemphigoid. Bullous Pemphigoid - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research